London

Resilience System

Main menu


You are here

Research

UPDATE: Moderna and Pfizer Reveal Secret Blueprints for Coronavirus Vaccine Trials

Two drug companies that are leading the race to develop coronavirus vaccines bowed to public pressure on Thursday, abandoning their traditional secrecy and releasing comprehensive road maps of how they are evaluating their vaccines.

The companies, Moderna and Pfizer, revealed details about how participants are being selected and monitored, the conditions under which the trials could be stopped early if there were problems, and the evidence researchers will use to determine whether people who got the vaccines were protected from Covid-19.

Moderna’s study will involve 30,000 participants, and Pfizer’s 44,000.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Eli Lilly reports first, promising results for an antibody against COVID-19

Today brings the first whisper of success for a class of closely watched drugs that it’s hoped will begin to beat back COVID-19 before vaccines are licensed: monoclonal antibodies, engineered versions of the same virus-fighting antibodies that the body naturally produces.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Research
howdy folks